We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCO icon
5001
ProShares UltraShort Bloomberg Crude Oil
SCO
$671M
$170K ﹤0.01%
117
-88
-43% -$208K
SI
5002
DELISTED
Silvergate Capital Corporation
SI
$170K ﹤0.01%
12,080
+7,379
+157% +$99.6K
HOOK
5003
DELISTED
HOOKIPA Pharma
HOOK
$169K ﹤0.01%
1,451
+902
+164% +$87.9K
IMVT icon
5004
Immunovant
IMVT
$7.93B
$169K ﹤0.01%
6,943
-13,233
-66% -$284K
DSKE
5005
DELISTED
Daseke, Inc. Common Stock
DSKE
$168K ﹤0.01%
42,672
+499
+1% +$1.1K
JNCE
5006
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$168K ﹤0.01%
24,328
-19,930
-45% -$108K
FDBC icon
5007
Fidelity D&D Bancorp
FDBC
$306M
$167K ﹤0.01%
3,464
+2,997
+642% +$120K
LEGH icon
5008
Legacy Housing
LEGH
$625M
$167K ﹤0.01%
11,755
+9,444
+409% +$107K
NVEC icon
5009
NVE Corp
NVEC
$562M
$167K ﹤0.01%
2,706
+1,054
+64% +$60.2K
PRTS icon
5010
CarParts.com
PRTS
$43.7M
$167K ﹤0.01%
1,929
+1,525
+377% +$81.2K
STZ.B
5011
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
$167K ﹤0.01%
960
BLBD icon
5012
Blue Bird Corp
BLBD
$2.35B
$166K ﹤0.01%
11,137
-45,357
-80% -$569K
GHM icon
5013
Graham Corp
GHM
$1.12B
$166K ﹤0.01%
13,050
-14,305
-52% -$175K
HALL
5014
DELISTED
Hallmark Financial Services, Inc.
HALL
$166K ﹤0.01%
4,770
+638
+15% +$21.4K
BWFG icon
5015
Bankwell Financial Group
BWFG
$543M
$165K ﹤0.01%
10,362
+1,548
+18% +$23K
GOEX icon
5016
Global X Gold Explorers ETF NEW
GOEX
$104M
$165K ﹤0.01%
5,176
+118
+2% +$3.23K
LVO icon
5017
LiveOne
LVO
$61.7M
$165K ﹤0.01%
4,564
+806
+21% +$22.5K
BCOV
5018
DELISTED
Brightcove, Inc.
BCOV
$165K ﹤0.01%
21,010
-61,708
-75% -$497K
DRN icon
5019
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.7M
$164K ﹤0.01%
16,310
+13,469
+474% +$127K
GB
5020
DELISTED
Global Blue Group Holding
GB
$164K ﹤0.01%
16,037
+9,797
+157% +$100K
SIC
5021
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$164K ﹤0.01%
47,174
+45,469
+2,667% +$133K
CAPR icon
5022
Capricor Therapeutics
CAPR
$223M
$163K ﹤0.01%
35,471
+33,746
+1,956% +$147K
USMF icon
5023
WisdomTree US Multifactor Fund
USMF
$298M
$163K ﹤0.01%
+5,479
New +$153K
HTB
5024
HomeTrust Bancshares
HTB
$860M
$163K ﹤0.01%
10,176
+71
+0.7% +$1.07K
SCWX
5025
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$163K ﹤0.01%
14,217
-6,447
-31% -$76.7K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.